Unfortunately, IL-2 immunotherapy is accompanied by substantial side effects such as acute episodes of capillary leak syndrome and reduction of neutrophil function, which are also triggered by the induction and high cytotoxicity of LAK cells [7]. The gene discussed is IL2; the disease is capillary leak syndrome.